 Connection
Lucas Orth to Cross-Sectional Studies
This is a "connection" page, showing publications Lucas Orth has written about Cross-Sectional Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.174 |
|
|
|
-
Feinstein JA, Feudtner C, Kempe A, Orth LE. Anticholinergic Medications and Parent-Reported Anticholinergic Symptoms in Neurologically Impaired Children. J Pain Symptom Manage. 2023 02; 65(2):e109-e114.
Score: 0.082
-
Jenkins AM, Hendry E, Power-Hays A, Valentino M, Hall M, Kyler KE, Antoon JW, Tang Girdwood S, Goldman JL, Morel AN, Savage TJ, Orth LE, Archer NM. Increasing ketamine administration in children's hospitals for youth with sickle cell disease. Blood Adv. 2026 Feb 24; 10(4):1106-1113.
Score: 0.026
-
Jenkins AM, Hendry E, Power-Hays A, Valentino M, Hall M, Kyler KE, Antoon JW, Tang Girdwood S, Goldman JL, Morel AN, Savage TJ, Orth LE, Archer NM. Increasing ketamine administration in children's hospitals for youth with sickle cell disease. Blood Adv. 2026 Feb 24; 10(4):1106-1113.
Score: 0.026
-
Tang Girdwood S, Hall M, Antoon JW, Kyler KE, Williams DJ, Shah SS, Orth LE, Goldman J, Feinstein JA, Ramsey LB. Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid. JAMA Netw Open. 2024 02 05; 7(2):e2355707.
Score: 0.022
-
Feinstein JA, Friedman H, Orth LE, Feudtner C, Kempe A, Samay S, Blackmer AB. Complexity of Medication Regimens for Children With Neurological Impairment. JAMA Netw Open. 2021 08 02; 4(8):e2122818.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|